Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2346 (LINC02346) is a human gene classified as a long intergenic non-coding RNA (lincRNA), meaning it is a transcript longer than 200 nucleotides that does not code for a protein and is located between protein-coding genes[1][3][5]. lincRNAs typically function in regulating chromatin structure, transcription, and RNA stability with high tissue specificity, but there is no current evidence indicating LINC02346 is a direct therapeutic target or has established roles in disease pathways[1][5][3]. LINC02346 is not a druggable target such as a receptor, enzyme, or transporter, but rather part of a growing class of non-coding RNAs implicated in gene expression regulation[5][7]. As of current databases, there are no known aliases beyond LINC02346, nor documented small-molecule interactions, biomarker applications, or safety/therapeutic data[1][3]. lincRNAs as a class are of increasing research interest for both basic biology and potential roles in disease, but LINC02346 itself is not yet linked to specific clinical applications or pathophysiologies[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2346 (LINC02346).